Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians
Annals of Internal Medicine
•
June 16, 2026
Semaglutide and tirzepatide lead weight-loss drugs
Damen JAA, Idema DL, Vernooij RWM, et al. Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity. Ann Intern Med . 2026;179:1140-1155.
- Level of evidence
- Level 1a
- DocG quality score
- 7.1 / 10
Read the full summary free
Patients, intervention, outcomes, results, and clinical applicability in about 300 words — plus new summaries in your inbox 3× per week.
Sign in with Google
